(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BLASILIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BLASILIN

ST13

US500000097201801

Class

5

Filing

97201801

Registration

7160338

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

09/12/2023

Trademark type

Word

Nice classes

5

Filing date

01/04/2022

Registration date

09/12/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/12/2023

Last transaction

09/12/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

BEIJING, CN

Examiner

OH, WON TEAK

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

GAN & LEE PHARMACEUTICALS.

Representatives

Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-diabetic pharmaceuticals; Biological preparations for the treatment of endocrine related diseases and disorders; Chemical preparations for pharmaceutical or medical purposesfor endocrine related diseases and disorders; Insulin; Medicinal herbal preparations; Medicinal preparations for metabolic system related diseases and disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of Diabetes; Syringes sold filled with insulin; Syringes sold filled with anti-diabetic pharmaceuticals

Publications

History of USPTO decisions and trademark events.

19 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/12/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/27/2023

PUBO

PUBLISHED FOR OPPOSITION

06/27/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/07/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

05/23/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

05/19/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/15/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

04/27/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

04/27/2023

CNSI

SUSPENSION INQUIRY WRITTEN

04/27/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

04/20/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/13/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/13/2022

GNSL

LETTER OF SUSPENSION E-MAILED

10/13/2022

CNSL

SUSPENSION LETTER WRITTEN

10/13/2022

DOCK

ASSIGNED TO EXAMINER

10/10/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/07/2022

NWAP

NEW APPLICATION ENTERED

01/07/2022

Continuous trademark protection

Get notified about every new filing that threatens BLASILIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.